Sort
23,748 grants matching “melanoma”
Targeting Hypoxia-Induced Cancer-Cell Adaptation by Direct Inhibition of Akt and
$485,596Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2011 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$485,561Fox Chase Cancer Center · U10 · FY2002 · CA
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
$485,465Edgar G. Engleman · Stanford University · R01 · FY2022 · CA
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
$485,465Edgar G. Engleman · Stanford University · R01 · FY2023 · CA
Community Outreach and Engagement
$485,385Judith R Rees · Dartmouth College · P30 · FY2025 · CA
Brain tumors with regulatory T-cells treated with EGFRvIII-specific T-cells
$485,104John H Sampson · Duke University · R01 · FY2014 · CA
Eukaryotic transcriptome engineering via sequence-specific regulation of endogenous RNA
$485,000Patrick Hsu · Salk Institute For Biological Studies · DP5 · FY2017 · OD
Eukaryotic transcriptome engineering via sequence-specific regulation of endogenous RNA
$485,000Patrick Hsu · Salk Institute For Biological Studies · DP5 · FY2015 · OD
Eukaryotic transcriptome engineering via sequence-specific regulation of endogenous RNA
$485,000Patrick Hsu · Salk Institute For Biological Studies · DP5 · FY2016 · OD
Intratumoral Cytokine Immunotherapy Studies in Companion Canine Cancer Models
$484,753Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2024 · CA
Applying Genomic Dosimeters of UV Damage to Predicting Skin Cancer Risk
$484,583Douglas E Brash · Yale University · R01 · FY2019 · ES
Community Outreach and Engagement
$484,562Carmen E Guerra · University Of Pennsylvania · P30 · FY2022 · CA
Role of lipid metabolism in CD8+ T cell ferroptosis
$484,536Qing Yi · Methodist Hospital Research Institute · R01 · FY2023 · CA
Role of lipid metabolism in CD8+ T cell ferroptosis
$484,536Qing Yi · Methodist Hospital Research Institute · R01 · FY2025 · CA
MITF from control of pigmentation to melanoma risk
$484,419David E Fisher · Massachusetts General Hospital · R01 · FY2025 · AR
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
$484,305William R Roush · Scripps Florida · R01 · FY2014 · CA
The identification of genetic determinants of melanoma recurrence
$484,247Tomas Kirchhoff · New York University School Of Medicine · R01 · FY2017 · CA
Cell and Gene Therapy, Clinical Manufacture and Monitoring Core
$484,169Antoni Ribas · California Institute Of Technology · P01 · FY2014 · CA
Molecular Interactions during Neural Crest Formation
$483,970Martin Ignacio Garcia-Castro · University Of California Riverside · R01 · FY2022 · DE
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
$483,799University Of Virginia Charlottesville · R37 · FY2002 · AI
Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancer
$483,730Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Project 2: Combined CAR-T cell therapy
$483,710Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2023 · CA
Non-coding RNA regulation of Myeloid Cells
$483,706Jorge Henao-Mejia · University Of Pennsylvania · R01 · FY2024 · CA
(PQD5) Mass Profiling Melanoma Responses to Improve Therapy Choices and Prognosis
$483,693Michael A Teitell · University Of California Los Angeles · R01 · FY2015 · CA
(PQD5) Mass Profiling Melanoma Responses to Improve Therapy Choices and Prognosis
$483,693Michael A Teitell · University Of California Los Angeles · R01 · FY2016 · CA